← Open Payments lookup

LINDI CIGLAR: Open Payments

NPI 1558830968 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,508 in 180 payments from 16 companies in 2025. Trend: 2023 $2,727 · 2024 $3,195 · 2025 $3,508

Food & beverage: $2,836Consulting: $555Education: $118
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$576
Teva Pharmaceuticals USA, Inc.29$526
Vanda Pharmaceuticals Inc.21$400
Alkermes, Inc.14$302
Neurocrine BioSciences, Inc.22$292
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$272
Janssen Pharmaceuticals, Inc17$251
Otsuka America Pharmaceutical, Inc.15$242
ABBVIE INC.19$187
Lundbeck LLC5$120

Products named: FANAPT, INGREZZA, CAPLYTA, AUSTEDO XR, UZEDY, REXULTI, VRAYLAR, ARISTADA.

Industry payments across OK — which companies pay providers there.